Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 1;13(1):e2021008.
doi: 10.4084/MJHID.2021.008. eCollection 2021.

Coronavirus Disease 2019 (COVID-19) Severity in Patients with Thalassemias: A Nationwide Iranian Experience

Affiliations

Coronavirus Disease 2019 (COVID-19) Severity in Patients with Thalassemias: A Nationwide Iranian Experience

Mehran Karimi et al. Mediterr J Hematol Infect Dis. .
No abstract available

Keywords: COVID-19; IRAN; Thalassemia.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare no conflict of Interest.

Figures

Figure 1
Figure 1
Frequency of different comorbidities amongst the 3 groups of confirmed COVID-19 patients with β-thalassemias based on disease severity.

References

    1. European Centre for Disease Prevention and Control. COVID-19 situation update worldwide, as of September 7, 2020. https://www.ecdceuropa.eu/en/geographical-distribution-2019-ncov-cases.
    1. Peng F, Tu L, Yang Y, Hu P, Wang R, Hu Q, Cao F, Jiang T, Sun J, Xu G, Chang C. Management and Treatment of COVID-19: The Chinese Experience. Can J Cardiol. 2020;36:915–930. doi: 10.1016/j.cjca.2020.04.010. - DOI - PMC - PubMed
    1. De Sanctis V, Canatan D, Corrons JLV, Karimi M, Daar S, Kattamis C, Soliman AT, Wali Y, Alkindi S, Huseynov V, Nasibova A, Tiryaki TO, Evim MS, Gunes AM, Karakas Z, Christou S, Campisi S, Zarei T, Khater D, Oymak Y, Kaleva V, Stoyanova D, Banchev A, Galati MC, Yassin MA, Kakar S, Skafida M, Kilinc Y, Alyaarubi S, Verdiyevas N, Stoeva I, Raiola G, Mariannis D, Ruggiero L, Di Maio S. Preliminary Data on COVID-19 in patients with hemoglobinopathies: A multicentre ICET-A study. Mediterr J Hematol Infect Dis. 2020 Jul 1;12(1):e2020046. doi: 10.4084/MJHID.2020.046. doi: 10.4084/mjhid.2020.046. - DOI - PMC - PubMed
    1. Karimi M, De Sanctis V. Implications of SARSr-CoV 2 infection in thalassemias: Do patients fall into the “high clinical risk” category? Acta Biomed. 2020;91:50–56. - PMC - PubMed
    1. He W, Chen L, Chen L, Yuan G, Fang Y, Chen W, Wu D, Liang B, Lu X, Ma Y, Li L, Wang H, Chen Z, Li Q, Gale RP. COVID-19 in persons with haematological cancers. Leukemia. 2020;34:1637–1645. doi: 10.1038/s41375-020-0836-7. - DOI - PMC - PubMed